Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likely

Journal of Clinical Epidemiology

Volumn 56, Issue 6, 2003, Pages 546-552

  Yan, Yan ^a   Hoover, Donald R ^b   Moore, Richard D ^c   Xiong, Chengjie ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cohort prevalence; Competing risks; Cumulative incidence; Morbidity time; Proportional hazards

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COHORT ANALYSIS; DEATH; HAZARD ASSESSMENT; HEALTH CARE PLANNING; HIGH RISK POPULATION; HOSPITAL; HUMAN; INCIDENCE; MATHEMATICAL ANALYSIS; MORBIDITY; MULTIVARIATE ANALYSIS; PATIENT INFORMATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TECHNIQUE;

EID: 0038503527     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(03)00057-X     Document Type: Article

References (14)

1. Anderson P.K., Gill R.D., Keiding N. Statistical models based on counting processes. 1993;Springer-Verlag, New York.
2. Hoover D.R., Peng Y., Saah A.J., Detels R.R., Day R.S., Phair J.P. Using multiple decrement model to estimate risk and morbidity from specific AIDS illnesses. Stat Med. 15:1996;2307-2321.
3. Hoover D.R., Peng Y., Saah A.J., Detels R.R., Rinaldo C.R., Phair J.P. Projecting disease when death is likely. Am J Epidemiol. 143:(9):1996;943-952.
4. Hoover D.R., Peng Y., Saah A.J., Semba R., Detels R.R., Rinaldo C.R., et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 114:1996;821-827.
5. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
6. Aalen O.O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat. 6:1978;534-545.
7. Cox D.R. Regression models and life-tables (with discussion). J R Stat Soc B. 34:1972;187-220.
8. Prentice R.L., Kalbfleisch J.D., Peterson A., Flournoy N., Farwell V.T., Breslow N.E. The analysis of failure times in the presence of competing risk. Biometrics. 34:1978;541-554.
9. Breslow N. Covariance analysis of censored survival data. Biometrics. 30:1974;89-99.
10. Efron B., Tibshirani R. An introduction to the boostrap. 1993;Chapman and Hall, London.
11. Gallant J.E., Moore R.D., Richman D.D., Keruly J., Chaisson R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodecifiency virus disease treated with Zidovudine. J Infect Dis. 166:1992;1223-1227.
12. Bowen E.F., Griffiths P.D., Davey C.C., Emery V.C., Johnson M.A. Lessons from the natural history of cytomegalovirus. AIDS. 10:(Suppl 1):1996;s37-s41.
13. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data. 1980;John Wiley & Sons, Inc. New York.
14. Yan Y., Moore R.D., Hoover D.R. Competing risk adjustment reduces overestimation of opportunistic infection in AIDS. J Clin Epidemiol. 53:2000;817-822.